Celiac Disease Pipeline Highlights - 2018

  • ID: 4516472
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Celiac Disease Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Celiac Disease market. It covers emerging therapies for Celiac Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Celiac Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Celiac Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Celiac Disease pipeline products by the company.

Short-term Launch Highlights:
Find out which Celiac Disease pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Celiac Disease phase 3 clinical trial pipeline products
  • Celiac Disease phase 2 clinical trial pipeline products
  • Celiac Disease phase 1 clinical trial pipeline products
  • Celiac Disease preclinical research pipeline products
  • Celiac Disease discovery stage pipeline products
  • Celiac Disease pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Celiac Disease Pipeline by Stages
2. Celiac Disease Pipeline by Drug Class
3. Celiac Disease Pipeline by Company
4. Celiac Disease Phase 3 Clinical Trial Insights
5. Celiac Disease Phase 2 Clinical Trial Insights
6. Celiac Disease Phase 1 Clinical Trial Insights
7. Celiac Disease Preclinical Research Insights
8. Celiac Disease Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Celiac Disease Phase 3 Clinical Trials, 2018
Table 2: Celiac Disease Phase 2 Clinical Trials, 2018
Table 3: Celiac Disease Phase 1 Clinical Trials, 2018
Table 4: Celiac Disease Preclinical Research, 2018
Table 5: Celiac Disease Discovery Stage, 2018

List of Figures
Figures 1: Celiac Disease Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Celiac Disease Pipeline Molecules by Drug Class, 2018
Figure 3: Celiac Disease Pipeline Molecules by Company, 2018
Figure 4: Celiac Disease Phase 3 Clinical Trial Highlights, 2018
Figure 5: Celiac Disease Phase 2 Clinical Trial Highlights, 2018
Figure 6: Celiac Disease Phase 1 Clinical Trial Highlights, 2018
Figure 7: Celiac Disease Preclinical Research Highlights, 2018
Figure 8: Celiac Disease Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll